// App-Quantinova.ai

OC7.2 : The role of the tumour microenvironment in pituitary adenoma angiogenesis

Researchers

Presenter

  • Pedro Marques

Principal Investigators

  • Sayka Barry

  • Eivind Carlsen

  • David Collier

  • Amy Ronaldson

  • Sherine Awad

  • Nigel Mendoza

  • Samiul Muquit

  • Neil Dorward

  • Joan Grieve

  • Frances Balkwill

  • Ashley B Grossman

  • Marta Korbonits

Medical Centers

  • William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Centre for Experimental Medicine & Rheumatology, London, United Kingdom

  • STHF, Skien, Norway, Department of Pathology, Skien, Norway

  • Imperial College Healthcare NHS Trust, London, UK, Department of Neurosurgery, London, United Kingdom

  • Derriford Hospital, Plymouth, UK, Department of Neurosurgery, Plymouth, United Kingdom

  • The National Hospital for Neurology and Neurosurgery, UCLH, NHS Trust, London, UK, Department of Neurosurgery, London, United Kingdom

  • Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

Locations

  • United Kingdom

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pituitary adenomas

Biomarkers

  • Microvessel density

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 163

  • Cluster of Differentiation 31

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Cytokine

  • Forkhead Box P3

  • Human Leukocyte Antigen – DR isotype

Drug/Treatment

  • Elaszym

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved